In addition, sodium glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists are novel diabetes medications that prevent kidney failure (5). The gene discussed is SLC5A2; the disease is diabetes mellitus.